NCT02808572View on ClinicalTrials.gov

New Biomarkers of Bone Mineral Metabolism as Cardiovascular Risk Factors in Chronic Kidney Disease Patients

NARecruitingINTERVENTIONAL
Enrollment

250

Participants

Timeline

Start Date

March 12, 2013

Primary Completion Date

March 31, 2024

Study Completion Date

June 30, 2031

Conditions
Chronic Kidney Disease
Interventions
BIOLOGICAL

Plasma osteoprotegerin level

dosage of plasma osteoprotegerin

BIOLOGICAL

Plasma fibroblast growth factor 23 level

dosage of plasma fibroblast growth factor 23

PROCEDURE

Vascular calcification score

measurement of vascular calcification score by multidetection computerized tomography

Trial Locations (7)

Unknown

RECRUITING

AIDER, Montpellier

ACTIVE_NOT_RECRUITING

CHU Montpellier, Cardiology department, Montpellier

RECRUITING

CHU Montpellier, Endocrinology department, Montpellier

ACTIVE_NOT_RECRUITING

CHU Montpellier, Intensive care unit, Montpellier

ACTIVE_NOT_RECRUITING

CHU Montpellier, Internal medicine department, Montpellier

RECRUITING

CHU Montpellier, Nephrology department, Montpellier

NOT_YET_RECRUITING

AIDER, Saint-Jean-de-Védas

All Listed Sponsors
lead

University Hospital, Montpellier

OTHER